Beyond blood flow —
desire, connection, and function
Most ED medications address one pathway. This compounded multi-ingredient formula combines tadalafil, PT-141, and oxytocin — addressing blood flow, desire activation, and emotional connection in a single physician-reviewed treatment.
Start your free intake →When blood flow alone
isn't the whole story
Male sexual function involves more than blood flow. For many men — particularly those who have had partial results with standard PDE5 inhibitors — the missing piece is desire and connection.
The combination formula is designed for that gap. Tadalafil handles the vascular pathway. PT-141 targets desire and arousal activation. Oxytocin supports the emotional dimension of intimacy.
Together, the three ingredients address the full spectrum of male sexual health — not just the mechanical component that standard ED medication reaches.
Three ingredients.
Three distinct pathways.
Each ingredient in the combination formula targets a different aspect of male sexual function.
About this formulation: Compounded multi-ingredient formula — not FDA-approved. Your provider will discuss the evidence base during review.
Other ED treatments
Not sure which option is right for you? Your physician will help determine the best fit based on your health history and goals.
Combo Formula
Multi-pathway · Desire + blood flow + connection
Current selectionWhat men ask about
the combination formula
Why add PT-141 to tadalafil?
What does oxytocin do?
Is this stronger than standard tadalafil?
Will I feel nauseous?
Can I take it every day?
What if standard ED meds haven't worked?
Blood flow, desire, and connection —
addressed together
For men who want comprehensive sexual health support beyond standard ED medication.
Start your free intake →Important Safety Information
Compounded multi-ingredient prescription — not FDA-approved. Do not take with nitrates. PT-141 may cause transient blood pressure increases. Nausea possible. Oxytocin evidence in male sexual function is limited. No prescription guaranteed without provider approval.